Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT06378021
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06378021
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06378021. Randomized; no masking; primary purpose prevention. Start 2024-03-14 (actual); primary completion 2025-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Calcium Chloride
- Intervention (Drug)
- Sodium Chloride 0.9% Inj
- Lead sponsor
- Helwan University
Record details
- Record id
cardio:ct-nct06378021- Content hash
f51dc0fabbee75cc89c5405cd5bcda574267e9a2393c1b746cfb5c9d40c79350